Birdwatch Note
2024-10-12 13:18:12 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Los ensayos clínicos de fase III de las vacunas del SARS-COV-2 siempre han tenido grupo de control con placebo. Por ejemplo, aquí los datos de Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165083/
Written by 1F0C0A0B4E767578D21FF93EF66F81EC4037E76BCC7787CD6526F07AA57808E9
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1844666147469148383
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1845091602446024995
- noteId - 1845091602446024995
- participantId -
- noteAuthorParticipantId - 1F0C0A0B4E767578D21FF93EF66F81EC4037E76BCC7787CD6526F07AA57808E9 Participant Details
- createdAtMillis - 1728739092824
- tweetId - 1844666147469148383
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Los ensayos clínicos de fase III de las vacunas del SARS-COV-2 siempre han tenido grupo de control con placebo. Por ejemplo, aquí los datos de Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165083/
Note Ratings
| rated at | rated by | |
| 2024-10-12 09:56:17 -0500 | Rating Details | |
| 2024-10-13 07:20:00 -0500 | Rating Details | |
| 2024-10-12 12:05:03 -0500 | Rating Details | |
| 2024-10-12 09:49:17 -0500 | Rating Details | |
| 2024-10-12 08:21:58 -0500 | Rating Details | |
| 2024-10-12 11:05:32 -0500 | Rating Details | |
| 2024-10-13 05:22:15 -0500 | Rating Details | |
| 2024-10-12 14:40:12 -0500 | Rating Details | |
| 2024-10-12 12:42:47 -0500 | Rating Details | |
| 2024-10-12 11:37:12 -0500 | Rating Details | |
| 2024-10-12 10:17:50 -0500 | Rating Details |